ST

Sanesh Tomar

Active Director Director DIN 09813039
DIN 09813039 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Sanesh Tomar

Data last updated:

Sanesh Tomar is a Director at Benaze Pharma Private Limited (since 2022). The company operates in Healthcare. Benaze Pharma Private Limited reported revenue of ₹16.4 Lakh (FY 2024).

DIN 09813039
Primary Designation Director
Industry Healthcare
First Appointment 05 Dec 2022
Oldest Company Age 3 yrs
Largest company Benaze Pharma Private Limited · ₹16.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Benaze Pharma Private Limited U85100UP2022PTC174437
Director05 Dec 20222022₹16.4 Lakh (FY 2024)Active

Board colleagues of Sanesh Tomar

NameDINCompanyDesignation
Shubham Tomar09779154Benaze Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Benaze Pharma Private Limited
Premium access

Shareholding and investment profile for Sanesh Tomar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanesh Tomar

Sanesh Tomar currently holds 1 directorship: Benaze Pharma Private Limited (Director, since 05 Dec 2022, revenue ₹16.4 Lakh (FY 2024)).

Sanesh Tomar was first appointed on 05 Dec 2022 as Director at Benaze Pharma Private Limited.

The current boards of Sanesh Tomar's companies include Shubham Tomar (Benaze Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available